CD24 and neoplasm: The interaction between sialylated CD24 on tumor cells and inhibitory Siglecs on macrophages forms the CD24-Siglecs axis, which serves as a glycol-immune checkpoint, enhancing immunosuppression and promoting tumor growth [3].